Skip To Main Content

Koulutusvideot

Järjestä

Suodattimet

Nollaa
  • Terapia-alue
The Hematology Podcast - Season 2

The Hematology Podcast - Season 2

The Hematology Podcast - Season 1

The Hematology Podcast - Season 1

Polyp Gossip – Episode 1

Polyp Gossip – Episode 1: Surgical Whispers: Is One Surgery Enough Before Starting Biologics?

Welcome to the debut episode of Polyp Gossip! In this episode, our expert panel explores a critical question in CRSwNP management: Is one surgery enough before starting biologics?

Polyp Gossip – Episode 2

Polyp Gossip – Episode 2: Scent-sational Secrets: The Smell Loss Truth

We explore the impact of smell impairment and its connection to CRSwNP. Featuring insights from our hosts and a special guest, we uncover pathways to recovery and improved quality of life.

Hot topics in atopic dermatitis: Longterm Control in AD

Hot topics in atopic dermatitis: Longterm Control in AD

Early Detection and Surveillance of Autoimmune Type 1 Diabetes

Early Detection and Surveillance of Autoimmune Type 1 Diabetes

Atopic Dermatitis in Melanin-Rich Skin - A DermTalks Webinar

Atopic Dermatitis in Melanin-Rich Skin - A DermTalks Webinar

Cardiovascular management in patients with Fabry disease

Cardiovascular management in patients with Fabry disease

Management in Patients with Fabry Disease.

Understanding Cardiovascular Risk and Prevention: Insights from Professor Pasquale Perrone-Filardi

Understanding Cardiovascular Risk and Prevention: Insights from Professor Pasquale Perrone-Filardi

Preventive Cardiology: Key Insights from Professor Michal Vrablik

Preventive Cardiology: Key Insights from Professor Michal Vrablik

Personalized approach in T2D is key for success

Personalized approach in T2D is key for success

The Sanofi webinar ‘Act Now for Impact: Glycemic Control and Beyond’ focuses on recent advancements in treating type 2 diabetes (T2D), emphasizing a personalized approach for better outcomes. Prof. Frank Nobels (Belgium), prof. De Galan (the Netherlands) and Prof Björn Eliasson (Sweden) addressed various aspects of T2D treatment in the present era.

EADV24 Highlights

EADV24 Highlights